Cathie Wood’s Ark Funds Built Up Big Stakes in Crispr Stock. Now It’s Tumbling.

 Cathie Wood’s Ark Funds Built Up Big Stakes in Crispr Stock. Now It’s Tumbling.

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.

https://www.barrons.com/articles/cathie-woods-ark-funds-crispr-51634129432


  • Order Reprints

  • Print Article

Crispr Therapeutics stock was tumbling Wednesday after the results of an experimental treatment from the gene-based medicine specialist underwhelmed investors. 

That is bad news for high-profile investor Cathie Wood, whose Ark Investment Management recently bought shares in the biotech company for two of its actively managed exchange-traded funds (ETFs). 

The…


Related post